Protocol for a multicentre, double-blind, randomised, placebo-controlled trial of riociguat on peak cardiac index during exercise in patients with chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty (THERAPY-HYBRID-BPA trial).
BMJ open（2023）
摘要
NCT04600492.
更多查看译文
关键词
pulmonary angioplasty,pulmonary hypertension,peak cardiac index,chronic thromboembolic,double-blind,placebo-controlled,therapy-hybrid-bpa
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要